Delivery Order SPE2DB24D3013-SPE2DB26FFGGZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,274.88 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML insulin pens on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,226.80 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens, with an award date of August 25, 2025 and ultimate completion date of August 26, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL) on September 9, 2025, with completion expected by September 10, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- The Defense Logistics Agency (DLA) awarded a $2,859.79 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens under a firm fixed-price contract type. The award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,227.36 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract, which is non-set-aside and competitively awarded, employs firm fixed-price pricing and was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $1,200.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,033.47 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with performance scheduled for completion by August 18, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,400.29 on June 2, 2025, for the supply of Lantus SoloStar 100 Unit/ml 3ml insulin pens. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The product will be delivered to...
- AmerisourceBergen Drug Corp was awarded a $1,197.07 firm fixed-price delivery order by the Defense Logistics Agency on July 18, 2025, for Lantus SoloStar 100 Unit/ML 3ML insulin pens. This is a non-set-aside competitive award with an ultimate completion date of July 21, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $4,157.91 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ml 3ml insulin pens, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFGGZDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,662.30 for Lantus SoloStar 100 Unit/mL 3mL insulin pens on November 10, 2025, with completion scheduled for November 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a continuation of the company's pharmaceutical supply chain support to federal healthcare systems. The award was issued as a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards covering a wide spectrum of pharmaceutical products and medical supplies, ranging from diabetes medications to specialized therapeutic treatments. Under the SPE2DX indefinite delivery vehicle and related delivery orders, AmerisourceBergen supplies essential medications, vaccines, and medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 11/10/25 |